A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain

An Open Label, Non-comparative, Multicentre Study to Evaluate the Efficacy and Tolerability of Pregabalin in Peripheral Neuropathic Pain

The purpose of this study is to evaluate the efficacy and safety of Lyrica in Indian patients with nerve pain

Inclusion criteria:

• Peripheral neuropathic pain
• Score of at least 40 mm on the VAS of the SF-MPQ at screening and baseline
• Completion of at least 4 daily pain diary entries with an average daily pain score of at least 4 over the 7 days prior to baseline

Exclusion criteria:

(none)